Mesa Laboratories, Inc. (MLAB) NASDAQ
104.38
-2.28(-2.14%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
104.38
-2.28(-2.14%)
Currency In USD
| Previous Close | 106.66 |
| Open | 106.16 |
| Day High | 106.16 |
| Day Low | 101.68 |
| 52-Week High | 111.29 |
| 52-Week Low | 55.45 |
| Volume | 131,024 |
| Average Volume | 141,041 |
| Market Cap | 576.68M |
| PE | 86.26 |
| EPS | 1.21 |
| Moving Average 50 Days | 97.94 |
| Moving Average 200 Days | 82.86 |
| Change | -2.28 |
Mesa Laboratories Announces CEO Transition and Appointment of Siddhartha Kadia as President and CEO
GlobeNewswire Inc.
Mar 09, 2026 8:30 PM GMT
LAKEWOOD, Colo., March 09, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced that
Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
GlobeNewswire Inc.
Dec 19, 2025 12:00 AM GMT
LAKEWOOD, Colo., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced that Gary Owens, President and CEO
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 3, 2026
GlobeNewswire Inc.
Dec 03, 2025 10:35 PM GMT
LAKEWOOD, Colo., Dec. 03, 2025 (GLOBE NEWSWIRE) -- - Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2026 at approximately 8:00 A.M. Eastern Time (ET) on Tuesday, Februar